L’Agenzia Italiana del Farmaco, in accordo con l’Agenzia Europea dei
Medicinali, rende disponibili nuove ed importanti raccomandazioni aggiornate conseguenti a un riesame a livello europeo dei benefici e dei rischi sull'uso di metoclopramide.
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Risk of serious or life-threatening allergic reaction.
Production facility in Vietnam reviewing manufacturing sterility controls.
L’Agenzia Italiana del Farmaco, in accordo con l’Agenzia Europea dei
Medicinali, rende disponibili nuove ed importanti informazioni su Abraxane.
Inadvertent overdose from prescription combination drugs containing acetaminophen accounts for nearly half of all cases of acetaminophen-related liver failure in the United States, some of which result in liver transplant or death.
Cartridge leak could potentially result in the device delivering too much or too little insulin.
Undeclared Chlorzoxazone, Nefopam, Diclofenac, Ibuprofen, Naproxen, and Indomethacin. Pro ArthMax has a reasonable probability of resulting in fatal adverse events.
L’Agenzia Italiana del Farmaco, in accordo con l’Agenzia Europea dei
Medicinali, rende disponibili nuove ed importanti informazioni sul rischio di tromboembolia in associazione con alcuni contraccettivi ormonali combinati1 (COC).
80.211.154.110
